Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 09, 2024 16:01 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company dedicated to the global development and...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
May 09, 2024 14:51 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
Fluent, Inc. to Announce 2024 First Quarter Financial Results on May 15, 2024
May 09, 2024 13:19 ET
|
Fluent, Inc.
Fluent, Inc. to Announce 2024 First Quarter Financial Results on May 15, 2024
Inter&Co Inc. Reports Record Profit
May 09, 2024 09:01 ET
|
Inter&Co, Inc
BELO HORIZONTE, Brazil, May 09, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the premier financial super app that provides financial and digital commerce services to over...
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
May 09, 2024 08:30 ET
|
Quoin Pharmaceuticals, Inc.
FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton Syndrome combination product Cash runway extended into...
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss Per Share on Continued Growth in Remote Monitoring and Control Hardware and Services Revenue
May 09, 2024 07:58 ET
|
Acorn Energy, Inc.
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss on Continued Growth in Remote Monitoring & Control Hardware & Services Revenue 11am call 844-834-0644
Kelly Reports First-Quarter 2024 Earnings
May 09, 2024 07:30 ET
|
Kelly Services, Inc.
Q1 operating earnings of $26.8 million, or up 34% on an adjusted basis Q1 revenue down following sale of European staffing operations; down 2.6% on an organic basis Q1 adjusted EBITDA margin increased...
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
May 09, 2024 07:04 ET
|
Standard Lithium
STRATEGIC EXECUTION SECURES LEADING GLOBAL ENERGY PARTNER, EQUINOR. INJECTS IMMEDIATE LIQUIDITY THROUGH DIRECT INVESTMENTS IN SOUTH WEST ARKANSAS AND EAST TEXAS PROJECTS PARTNERSHIP BRINGS...
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and...
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook
May 09, 2024 07:00 ET
|
LanzaTech Inc.
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook